Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001012289 | SCV001172722 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001465734 | SCV001669726 | likely benign | Ataxia-telangiectasia syndrome | 2015-10-30 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001012289 | SCV002532738 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-03-06 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV004589884 | SCV005084208 | benign | Familial cancer of breast | 2024-04-29 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |